Microbe-based management for colorectal cancer
Colorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely related to the pathogenesis and prognosis of CRC. The normal microbiota plays an essential role in maintaining gut barrier function and the i...
Saved in:
| Published in | Chinese medical journal Vol. 134; no. 24; pp. 2922 - 2930 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
China
Lippincott Williams & Wilkins
01.12.2021
Lippincott Williams & Wilkins Ovid Technologies State Key Laboratory for Oncogenes and Related Genes Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China%Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China Division of Gastroenterology and Hepatology Key Laboratory of Gastroenterology & Hepatology, Ministry of Health Shanghai Cancer Institute Shanghai Institute of Digestive Disease Wolters Kluwer |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Colorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely related to the pathogenesis and prognosis of CRC. The normal microbiota plays an essential role in maintaining gut barrier function and the immune microenvironment. Recent studies have identified carcinogenic bacteria such as enterotoxigenic Bacteroides fragilis (ETBF) and Streptococcus gallolyticus (S. gallolyticus), as well as protective bacterial such as Akkermansia muciniphila (A. muciniphila), as potential targets of CRC treatment. Gut microbiota modulation aims to restore gut dysbiosis, regulate the intestinal immune system and prevent from pathogen invasion, all of which are beneficial for CRC prevention and prognosis. The utility of probiotics, prebiotics, postbiotics, fecal microbiota transplantation and dietary inventions to treat CRC makes them novel microbe-based management tools. In this review, we describe the mechanisms involved in bacteria-derived colorectal carcinogenesis and summarized novel bacteria-related therapies for CRC. In summary, we hope to facilitate clinical applications of intestinal bacteria for preventing and treating CRC. |
|---|---|
| AbstractList | Colorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely related to the pathogenesis and prognosis of CRC. The normal microbiota plays an essential role in maintaining gut barrier function and the immune microenvironment. Recent studies have identified carcinogenic bacteria such as enterotoxigenic Bacteroides fragilis (ETBF) and Streptococcus gallolyticus (S. gallolyticus), as well as protective bacterial such as Akkermansia muciniphila (A. muciniphila), as potential targets of CRC treatment. Gut microbiota modulation aims to restore gut dysbiosis, regulate the intestinal immune system and prevent from pathogen invasion, all of which are beneficial for CRC prevention and prognosis. The utility of probiotics, prebiotics, postbiotics, fecal microbiota transplantation and dietary inventions to treat CRC makes them novel microbe-based management tools. In this review, we describe the mechanisms involved in bacteria-derived colorectal carcinogenesis and summarized novel bacteria-related therapies for CRC. In summary, we hope to facilitate clinical applications of intestinal bacteria for preventing and treating CRC.ABSTRACTColorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely related to the pathogenesis and prognosis of CRC. The normal microbiota plays an essential role in maintaining gut barrier function and the immune microenvironment. Recent studies have identified carcinogenic bacteria such as enterotoxigenic Bacteroides fragilis (ETBF) and Streptococcus gallolyticus (S. gallolyticus), as well as protective bacterial such as Akkermansia muciniphila (A. muciniphila), as potential targets of CRC treatment. Gut microbiota modulation aims to restore gut dysbiosis, regulate the intestinal immune system and prevent from pathogen invasion, all of which are beneficial for CRC prevention and prognosis. The utility of probiotics, prebiotics, postbiotics, fecal microbiota transplantation and dietary inventions to treat CRC makes them novel microbe-based management tools. In this review, we describe the mechanisms involved in bacteria-derived colorectal carcinogenesis and summarized novel bacteria-related therapies for CRC. In summary, we hope to facilitate clinical applications of intestinal bacteria for preventing and treating CRC. Colorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely related to the pathogenesis and prognosis of CRC. The normal microbiota plays an essential role in maintaining gut barrier function and the immune microenvironment. Recent studies have identified carcinogenic bacteria such as enterotoxigenic Bacteroides fragilis (ETBF) and Streptococcus gallolyticus (S. gallolyticus), as well as protective bacterial such as Akkermansia muciniphila (A. muciniphila), as potential targets of CRC treatment. Gut microbiota modulation aims to restore gut dysbiosis, regulate the intestinal immune system and prevent from pathogen invasion, all of which are beneficial for CRC prevention and prognosis. The utility of probiotics, prebiotics, postbiotics, fecal microbiota transplantation and dietary inventions to treat CRC makes them novel microbe-based management tools. In this review, we describe the mechanisms involved in bacteria-derived colorectal carcinogenesis and summarized novel bacteria-related therapies for CRC. In summary, we hope to facilitate clinical applications of intestinal bacteria for preventing and treating CRC. Colorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely related to the pathogenesis and prognosis of CRC. The normal microbiota plays an essential role in maintaining gut barrier function and the immune microenvironment. Recent studies have identified carcinogenic bacteria such as enterotoxigenic Bacteroides fragilis ( ETBF) and Streptococcus gallolyticus ( S. gallolyticus), as well as protective bacterial such as Akkermansia muciniphila ( A. muciniphila), as potential targets of CRC treatment. Gut microbiota modulation aims to restore gut dysbiosis, regulate the intestinal immune system and prevent from pathogen invasion, all of which are beneficial for CRC prevention and prognosis. The utility of probiotics, prebiotics, postbiotics, fecal microbiota transplantation and dietary inventions to treat CRC makes them novel microbe-based management tools. In this review, we describe the mechanisms involved in bacteria-derived colorectal carcinogenesis and summarized novel bacteria-related therapies for CRC. In summary, we hope to facilitate clinical applications of intestinal bacteria for preventing and treating CRC. Colorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely related to the pathogenesis and prognosis of CRC. The normal microbiota plays an essential role in maintaining gut barrier function and the immune microenvironment. Recent studies have identified carcinogenic bacteria such as enterotoxigenic Bacteroides fragilis ( ETBF ) and Streptococcus gallolyticus ( S. gallolyticus ), as well as protective bacterial such as Akkermansia muciniphila ( A. muciniphila ), as potential targets of CRC treatment. Gut microbiota modulation aims to restore gut dysbiosis, regulate the intestinal immune system and prevent from pathogen invasion, all of which are beneficial for CRC prevention and prognosis. The utility of probiotics, prebiotics, postbiotics, fecal microbiota transplantation and dietary inventions to treat CRC makes them novel microbe-based management tools. In this review, we describe the mechanisms involved in bacteria-derived colorectal carcinogenesis and summarized novel bacteria-related therapies for CRC. In summary, we hope to facilitate clinical applications of intestinal bacteria for preventing and treating CRC. |
| Abstract_FL | Colorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely related to the pathogenesis and prognosis of CRC. The normal microbiota plays an essential role in maintaining gut barrier function and the immune microenvironment. Recent studies have identified carcinogenic bacteria such as
enterotoxigenic Bacteroides fragilis (
ETBF) and
Streptococcus gallolyticus (
S. gallolyticus), as well as protective bacterial such as
Akkermansia muciniphila (
A. muciniphila), as potential targets of CRC treatment. Gut microbiota modulation aims to restore gut dysbiosis, regulate the intestinal immune system and prevent from pathogen invasion, all of which are beneficial for CRC prevention and prognosis. The utility of probiotics, prebiotics, postbiotics, fecal microbiota transplantation and dietary inventions to treat CRC makes them novel microbe-based management tools. In this review, we describe the mechanisms involved in bacteria-derived colorectal carcinogenesis and summarized novel bacteria-related therapies for CRC. In summary, we hope to facilitate clinical applications of intestinal bacteria for preventing and treating CRC. |
| Author | Yan, Yu-Qing Cui, Zhe Hong, Jie Ning, Li-Jun Gao, Zi-Yun Wang, Zhen-Hua |
| AuthorAffiliation | State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China |
| AuthorAffiliation_xml | – name: State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – name: Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – name: State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China%Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – name: 1 State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – name: 2 Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China |
| Author_FL | Yu-Qing Yan Li-Jun Ning Zhe Cui Zi-Yun Gao Zhen-Hua Wang Jie Hong |
| Author_FL_xml | – sequence: 1 fullname: Zi-Yun Gao – sequence: 2 fullname: Zhe Cui – sequence: 3 fullname: Yu-Qing Yan – sequence: 4 fullname: Li-Jun Ning – sequence: 5 fullname: Zhen-Hua Wang – sequence: 6 fullname: Jie Hong |
| Author_xml | – sequence: 1 givenname: Zi-Yun surname: Gao fullname: Gao, Zi-Yun organization: State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – sequence: 2 givenname: Zhe surname: Cui fullname: Cui, Zhe organization: Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – sequence: 3 givenname: Yu-Qing surname: Yan fullname: Yan, Yu-Qing organization: State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – sequence: 4 givenname: Li-Jun surname: Ning fullname: Ning, Li-Jun organization: State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – sequence: 5 givenname: Zhen-Hua surname: Wang fullname: Wang, Zhen-Hua organization: State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – sequence: 6 givenname: Jie surname: Hong fullname: Hong, Jie organization: State Key Laboratory for Oncogenes and Related Genes; Key Laboratory of Gastroenterology & Hepatology, Ministry of Health; Division of Gastroenterology and Hepatology; Shanghai Cancer Institute; Shanghai Institute of Digestive Disease; Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34855639$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFksuO0zAUhi00iOkU3gChSkiITcrxJY7NAglVXEaaERtYW8eO06Y48eCkVPD0OLRUM93gjSWf7__PxeeKXPSx94Q8p7CkoKs3q1u9hHuHKlU9IjNWClaUUtALMgMuZSG11pfkahi2AKwsK_mEXHKhylJyPSPL29alaH1hcfD1osMe177z_bhoYlq4GGLybsSwcNg7n56Sxw2GwT873nPy7eOHr6vPxc2XT9er9zeFKyslCmdBWymg0lQJ7y2FxlEJlKsaHFgqGl1rjko1jNeOS8EYtVYB1BVa74DPyfXBt464NXep7TD9MhFb8_chprXBNLYueFNLDSVHy7CmAj0oWqJktSuZ5qzJoTl5d_C629nO1y43lzA8MH0Y6duNWcefRlUUOGPZ4NXBYI99g_3abOMu9bl983vjui0DRpkAEBl8fcyU4o-dH0bTtYPzIWDv424wTILUHITQGX15hp5MmaSsYlyqKfOL-6Wfav73fxkQByB_4jAk35wQCmZaE5PXxJyvSZa9PZO5dsSxjdMA2vA_8THnPobRp-F72O19MhuPYdxMeB48h2IaC2UMoJiUgv8B3g7NXA |
| CitedBy_id | crossref_primary_10_3389_fmed_2022_1000563 crossref_primary_10_7717_peerj_15777 crossref_primary_10_1111_1759_7714_15096 crossref_primary_10_1128_spectrum_00135_23 crossref_primary_10_1016_j_compbiomed_2025_109813 crossref_primary_10_3390_nu15081815 crossref_primary_10_1007_s11684_022_0978_2 crossref_primary_10_1093_bib_bbad255 crossref_primary_10_3390_biomedicines10040827 crossref_primary_10_1080_19490976_2025_2452277 crossref_primary_10_3390_cells13171437 crossref_primary_10_3389_fonc_2024_1395966 |
| Cites_doi | 10.1097/MOG.0000000000000399 10.1080/21688370.2017.1373208 10.3389/fcimb.2019.00449 10.1186/s40168-018-0451-2 10.1053/j.gastro.2020.09.003 10.1016/j.chom.2013.07.007 10.1128/CMR.00053-08 10.1038/s41564-019-0541-3 10.3390/cancers13133178 10.1080/10408398.2020.1765310 10.1016/j.ccell.2018.03.004 10.1038/nm.2015 10.1371/journal.pone.0119462 10.1038/nrgastro.2017.75 10.1186/s40168-021-01071-4 10.1371/journal.ppat.1006440 10.3390/toxins5081462 10.1016/j.micpath.2016.02.005 10.1073/pnas.1912129116 10.1038/s41586-020-2729-3 10.1080/19490976.2020.1847629 10.1053/j.gastro.2019.10.020 10.1016/j.cell.2017.07.008 10.1038/s41467-021-21162-y 10.1053/j.gastro.2009.04.001 10.21315/mjms2020.27.4.2 10.1080/1040841X.2018.1481013 10.3389/fphar.2021.609992 10.3389/fimmu.2020.615056 10.1136/gutjnl-2020-322260 10.4161/gmic.1.4.12778 10.1016/j.jcmgh.2021.06.001 10.2217/fmb.15.66 10.1097/CM9.0000000000001474 10.1136/gutjnl-2018-317200 10.1073/pnas.1715112115 10.1016/j.ebiom.2017.10.005 10.4161/gmic.23919 10.3322/caac.21601 10.1016/j.chom.2018.01.007 10.1186/s13099-019-0306-9 10.1007/s13238-018-0543-6 10.1080/19490976.2015.1039223 10.1093/cid/cir609 10.1016/j.canlet.2019.11.019 10.1007/s00430-018-0542-5 10.3390/cancers12020372 10.1038/nrc3610 10.1038/nrgastro.2014.66 10.1111/cmi.12714 10.1099/ijs.0.02361-0 10.1155/2020/8884583 10.1038/s41575-019-0209-8 10.1053/j.gastro.2018.04.028 10.1080/19490976.2020.1869504 10.1002/jcp.28436 10.3322/caac.21492 10.1016/j.lfs.2021.119622 10.1053/j.gastro.2016.11.018 10.1016/S0140-6736(19)32319-0 10.1126/science.aan3706 10.3390/biomedicines9020144 10.1038/s41575-019-0189-8 10.3389/fimmu.2020.588079 10.1136/gutjnl-2019-318593 10.18632/oncotarget.5166 10.1136/gutjnl-2015-310912 10.1016/j.mam.2019.05.001 10.3390/cancers13092060 10.1186/1756-9966-30-11 10.1016/j.chom.2021.03.016 10.1136/gutjnl-2020-322780 10.12659/MSM.904220 10.1016/j.tifs.2018.03.009 10.1053/j.gastro.2017.08.022 10.1007/s00248-013-0245-9 10.1053/j.gastro.2021.08.003 10.1053/j.gastro.2017.01.009 10.1053/j.gastro.2021.07.008 10.1016/j.joim.2020.11.001 10.5217/ir.2018.00099 10.1136/gutjnl-2019-320105 10.1158/2326-6066.CIR-20-1019 10.1093/cid/ciu787 10.1053/j.gastro.2019.06.048 10.1016/j.chom.2013.07.012 |
| ContentType | Journal Article |
| Copyright | Lippincott Williams & Wilkins Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © Wanfang Data Co. Ltd. All Rights Reserved. Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2021 |
| Copyright_xml | – notice: Lippincott Williams & Wilkins – notice: Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. – notice: Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. – notice: Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. 2021 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 2B. 4A8 92I 93N PSX TCJ 5PM DOA |
| DOI | 10.1097/CM9.0000000000001887 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitle_FL | Microbe-based management for colorectal cancer |
| EISSN | 2542-5641 |
| EndPage | 2930 |
| ExternalDocumentID | oai_doaj_org_article_d69053ab2ad14ae0815a62dc52932f05 PMC8710322 zhcmj202124004 34855639 10_1097_CM9_0000000000001887 00029330-202112200-00004 |
| Genre | Journal Article Review |
| GroupedDBID | --- -05 -0E 0R~ 29B 2WC 40I 5GY 5RE 5VR 5VS 6J9 7X7 88E 8FI 8FJ 92F 92I 92M AAAAV AAHPQ AAIQE AASCR ABASU ABCQX ABDIG ABUWG ABVCZ ABZZY ACGFO ACGFS ACILI ACXJB ADGGA ADHPY ADPDF AENEX AFBFQ AFDTB AFKRA AHMBA AHQNM AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ ALIPV ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BENPR BPHCQ BQLVK BVXVI CCEZO CCPQU CHBEP CIEJG CW9 DIK DIWNM EBS EEVPB EJD F5P FA0 FCALG FRP FYUFA GNXGY GQDEL GROUPED_DOAJ GX1 HLJTE HMCUK HYE IAO IHR IKREB IPNFZ JUIAU KQ8 L7B M1P M48 OK1 OPUJH OVD OVDNE OVEED OXXIT P2P P6G PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RIG RLZ RNS RPM RT5 S.. T8U TCJ TEORI TGQ TR2 TSPGW U1F U5O UKHRP W2D WFFXF XSB AAYXX CITATION OVT CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 -SE -S~ .55 .GJ 2B. 4A8 53G 93N 9D9 9DE ADRAZ AFUIB AHVBC C1A CAJEE H13 IHW INH INR ITC PMFND PSX PV9 R-E RZL U1G U5E X7J X7M ZGI ZXP 5PM PUEGO |
| ID | FETCH-LOGICAL-c5784-cb09b64079184eeb10fc160138d0c0b14f9d93a88f23dc364221bb800d7abec03 |
| IEDL.DBID | M48 |
| ISSN | 0366-6999 2542-5641 |
| IngestDate | Wed Aug 27 01:24:39 EDT 2025 Thu Aug 21 17:58:17 EDT 2025 Thu May 29 04:05:50 EDT 2025 Fri Jul 11 10:53:12 EDT 2025 Fri Jul 25 09:34:33 EDT 2025 Mon Jul 21 06:05:15 EDT 2025 Thu Apr 24 22:56:30 EDT 2025 Thu Jul 03 08:35:51 EDT 2025 Fri May 16 03:56:30 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 24 |
| Keywords | Intestinal bacteria Management Fecal microbiota transplantation Colorectal cancer |
| Language | English |
| License | Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5784-cb09b64079184eeb10fc160138d0c0b14f9d93a88f23dc364221bb800d7abec03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1097/CM9.0000000000001887 |
| PMID | 34855639 |
| PQID | 2612723682 |
| PQPubID | 2042885 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d69053ab2ad14ae0815a62dc52932f05 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8710322 wanfang_journals_zhcmj202124004 proquest_miscellaneous_2606930449 proquest_journals_2612723682 pubmed_primary_34855639 crossref_primary_10_1097_CM9_0000000000001887 crossref_citationtrail_10_1097_CM9_0000000000001887 wolterskluwer_health_00029330-202112200-00004 |
| PublicationCentury | 2000 |
| PublicationDate | 20211201 |
| PublicationDateYYYYMMDD | 2021-12-01 |
| PublicationDate_xml | – month: 12 year: 2021 text: 20211201 day: 1 |
| PublicationDecade | 2020 |
| PublicationPlace | China |
| PublicationPlace_xml | – name: China – name: Baltimore – name: Hagerstown, MD |
| PublicationTitle | Chinese medical journal |
| PublicationTitleAlternate | Chin Med J (Engl) |
| PublicationTitle_FL | Chinese Medical Journal |
| PublicationYear | 2021 |
| Publisher | Lippincott Williams & Wilkins Lippincott Williams & Wilkins Ovid Technologies State Key Laboratory for Oncogenes and Related Genes Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China%Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China Division of Gastroenterology and Hepatology Key Laboratory of Gastroenterology & Hepatology, Ministry of Health Shanghai Cancer Institute Shanghai Institute of Digestive Disease Wolters Kluwer |
| Publisher_xml | – name: Lippincott Williams & Wilkins – name: Lippincott Williams & Wilkins Ovid Technologies – name: Key Laboratory of Gastroenterology & Hepatology, Ministry of Health – name: Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China%Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China – name: State Key Laboratory for Oncogenes and Related Genes – name: Division of Gastroenterology and Hepatology – name: Shanghai Cancer Institute – name: Shanghai Institute of Digestive Disease – name: Wolters Kluwer |
| References | Schlegel (R56-20250603) 2003; 53 Min Ho (R82-20250603) 2019; 17 Weng (R87-20250603) 2020 Yu (R37-20250603) 2017; 170 Saus (R9-20250603) 2019; 69 He (R47-20250603) 2019; 68 Cao (R5-20250603) 2021; 134 Parker (R83-20250603) 2021; 9 Derrien (R51-20250603) 2010; 1 Tulli (R64-20250603) 2013; 15 Bray (R2-20250603) 2018; 68 Chung (R73-20250603) 2021; 9 Gaines (R85-20250603) 2020; 158 Freitag (R46-20250603) 2017; 19 Fabbri (R41-20250603) 2013; 5 Fan (R54-20250603) 2021; 9 Ahmed S Abdulamir (R58-20250603) 2011; 30 Xing (R70-20250603) 2021; 29 Wang (R53-20250603) 2020; 69 Xie (R63-20250603) 2017; 25 Wong (R81-20250603) 2017; 153 Kostic (R33-20250603) 2013; 14 Gibson (R74-20250603) 2017; 14 Kumar (R60-20250603) 2017; 13 Fei (R77-20250603) 2021 Nguyen (R86-20250603) 2021; 161 Chung (R30-20250603) 2018; 23 Wang (R80-20250603) 2019; 234 Iftekhar (R39-20250603) 2021; 12 Schmidt (R45-20250603) 2019; 11 Arnold (R3-20250603) 2017; 66 Tsoi (R50-20250603) 2017; 152 Takiishi (R10-20250603) 2017; 5 Aymeric (R59-20250603) 2018; 115 Wong (R17-20250603) 2019; 16 Yang (R36-20250603) 2017; 152 Salesse (R40-20250603) 2021; 13 Rad (R79-20250603) 2021; 61 Zamani (R26-20250603) 2019; 9 Kwong (R19-20250603) 2018; 155 Xu (R15-20250603) 2020; 12 Keum (R4-20250603) 2019; 16 Hill (R65-20250603) 2014; 11 Schwabe (R8-20250603) 2013; 13 Wassenaar (R38-20250603) 2018; 44 Boleij (R57-20250603) 2011; 53 Liao (R76-20250603) 2021; 13 Allali (R43-20250603) 2015; 6 Hong (R35-20250603) 2021; 70 Chen (R90-20250603) 2020; 11 Sears (R25-20250603) 2009; 22 Derrien (R52-20250603) 2017; 106 Rubinstein (R34-20250603) 2013; 14 Lu (R23-20250603) 2021 Wu (R29-20250603) 2009; 15 Viljoen (R32-20250603) 2015; 10 Dai (R18-20250603) 2018; 6 Yu (R89-20250603) 2015; 6 Owens (R72-20250603) 2021; 12 Bertrand Routy (R55-20250603) 2018; 359 Lau (R20-20250603) 2021; 13 Chen (R69-20250603) 2015; 10 Boleij (R27-20250603) 2015; 60 Xu (R42-20250603) 2017; 23 Kim (R71-20250603) 2021; 11 Yang (R84-20250603) 2018; 9 Zhang (R22-20250603) 2019; 68 Long (R49-20250603) 2019; 4 Tripathy (R66-20250603) 2021; 13 Dekker (R16-20250603) 2019; 394 Chen (R68-20250603) 2020; 469 Li (R61-20250603) 2021; 160 Yang (R48-20250603) 2017; 33 Aguilar-Toalá (R78-20250603) 2018; 75 Sobhani (R12-20250603) 2019; 116 Wu (R24-20250603) 2013; 66 Dixit (R21-20250603) 2021; 278 Raman (R75-20250603) 2013; 4 Siegel (R1-20250603) 2020; 70 Tilg (R14-20250603) 2018; 33 Cao (R31-20250603) 2021; 161 Zhu (R88-20250603) 2021; 19 Janney (R13-20250603) 2020; 585 Ding (R67-20250603) 2020; 2020 Allali (R62-20250603) 2018; 207 Song (R6-20250603) 2020; 158 Wang (R91-20250603) 2021; 12 Cheng (R28-20250603) 2020; 27 Gradel (R44-20250603) 2009; 137 Cheng (R7-20250603) 2020; 11 Paone (R11-20250603) 2020; 69 |
| References_xml | – volume: 33 start-page: 422 year: 2017 ident: R48-20250603 article-title: Novel insights into microbiome in colitis and colorectal cancer publication-title: Curr Opin Gastroenterol doi: 10.1097/MOG.0000000000000399 – volume: 5 start-page: e1373208 year: 2017 ident: R10-20250603 article-title: Intestinal barrier and gut microbiota: shaping our immune responses throughout life publication-title: Tissue Barriers doi: 10.1080/21688370.2017.1373208 – volume: 9 start-page: 449 year: 2019 ident: R26-20250603 article-title: Enterotoxigenic bacteroides fragilis: a possible etiological candidate for bacterially-induced colorectal precancerous and cancerous lesions publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2019.00449 – volume: 6 start-page: 70 year: 2018 ident: R18-20250603 article-title: Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers publication-title: Microbiome doi: 10.1186/s40168-018-0451-2 – volume: 160 start-page: 1179 year: 2021 ident: R61-20250603 article-title: Streptococcus thermophilus inhibits colorectal tumorigenesis through secreting beta-galactosidase publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.09.003 – volume: 14 start-page: 207 year: 2013 ident: R33-20250603 article-title: Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment publication-title: Cell Host Microbe doi: 10.1016/j.chom.2013.07.007 – volume: 22 start-page: 349 year: 2009 ident: R25-20250603 article-title: Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00053-08 – volume: 4 start-page: 2319 year: 2019 ident: R49-20250603 article-title: Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity publication-title: Nat Microbiol doi: 10.1038/s41564-019-0541-3 – volume: 13 start-page: 3178 year: 2021 ident: R66-20250603 article-title: Probiotics: a promising candidate for management of colorectal cancer publication-title: Cancers (Basel) doi: 10.3390/cancers13133178 – volume: 61 start-page: 1787 year: 2021 ident: R79-20250603 article-title: Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2020.1765310 – volume: 33 start-page: 954 year: 2018 ident: R14-20250603 article-title: The intestinal microbiota in colorectal cancer publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.03.004 – volume: 15 start-page: 1016 year: 2009 ident: R29-20250603 article-title: A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses publication-title: Nat Med doi: 10.1038/nm.2015 – volume: 10 start-page: e0119462 year: 2015 ident: R32-20250603 article-title: Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer publication-title: PLoS One doi: 10.1371/journal.pone.0119462 – volume: 14 start-page: 491 year: 2017 ident: R74-20250603 article-title: Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2017.75 – volume: 9 start-page: 122 year: 2021 ident: R73-20250603 article-title: A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota publication-title: Microbiome doi: 10.1186/s40168-021-01071-4 – volume: 13 start-page: e1006440 year: 2017 ident: R60-20250603 article-title: Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1006440 – volume: 5 start-page: 1462 year: 2013 ident: R41-20250603 article-title: The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators publication-title: Toxins (Basel) doi: 10.3390/toxins5081462 – volume: 106 start-page: 171 year: 2017 ident: R52-20250603 article-title: Akkermansia muciniphila and its role in regulating host functions publication-title: Microb Pathog doi: 10.1016/j.micpath.2016.02.005 – volume: 116 start-page: 24285 year: 2019 ident: R12-20250603 article-title: Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1912129116 – volume: 585 start-page: 509 year: 2020 ident: R13-20250603 article-title: Host-microbiota maladaptation in colorectal cancer publication-title: Nature doi: 10.1038/s41586-020-2729-3 – volume: 13 start-page: 1847629 year: 2021 ident: R76-20250603 article-title: Bifidobacterium animalis: the missing link for the cancer-preventive effect of Gynostemma pentaphyllum publication-title: Gut Microbes doi: 10.1080/19490976.2020.1847629 – volume: 158 start-page: 958 year: 2020 ident: R85-20250603 article-title: Western diet promotes intestinal colonization by collagenolytic microbes and promotes tumor formation after colorectal surgery publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.10.020 – year: 2020 ident: R87-20250603 article-title: Curcumin and colorectal cancer: an update and current perspective on this natural medicine publication-title: Semin Cancer Biol – volume: 170 start-page: 548 year: 2017 ident: R37-20250603 article-title: Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy publication-title: Cell doi: 10.1016/j.cell.2017.07.008 – volume: 12 start-page: 1003 year: 2021 ident: R39-20250603 article-title: Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells publication-title: Nat Commun doi: 10.1038/s41467-021-21162-y – volume: 137 start-page: 495 year: 2009 ident: R44-20250603 article-title: Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis publication-title: Gastroenterology doi: 10.1053/j.gastro.2009.04.001 – start-page: 1 year: 2021 ident: R77-20250603 article-title: Role of prebiotics in enhancing the function of next-generation probiotics in gut microbiota publication-title: Crit Rev Food Sci Nutr – volume: 27 start-page: 9 year: 2020 ident: R28-20250603 article-title: The mechanism of bacteroides fragilis toxin contributes to colon cancer formation publication-title: Malays J Med Sci doi: 10.21315/mjms2020.27.4.2 – volume: 44 start-page: 619 year: 2018 ident: R38-20250603 article-title: E. coli and colorectal cancer: a complex relationship that deserves a critical mindset publication-title: Crit Rev Microbiol doi: 10.1080/1040841X.2018.1481013 – volume: 12 start-page: 609992 year: 2021 ident: R91-20250603 article-title: Sini decoction ameliorates colorectal cancer and modulates the composition of gut microbiota in mice publication-title: Front Pharmacol doi: 10.3389/fphar.2021.609992 – volume: 11 start-page: 615056 year: 2020 ident: R7-20250603 article-title: The intestinal microbiota and colorectal cancer publication-title: Front Immunol doi: 10.3389/fimmu.2020.615056 – volume: 69 start-page: 2232 year: 2020 ident: R11-20250603 article-title: Mucus barrier, mucins and gut microbiota: the expected slimy partners? publication-title: Gut doi: 10.1136/gutjnl-2020-322260 – volume: 1 start-page: 254 year: 2010 ident: R51-20250603 article-title: Mucin-bacterial interactions in the human oral cavity and digestive tract publication-title: Gut Microbes doi: 10.4161/gmic.1.4.12778 – volume: 12 start-page: 1311 year: 2021 ident: R72-20250603 article-title: Lactobacillus rhamnosus GG orchestrates an anti-tumor immune response publication-title: Cell Mol Gastroenterol Hepatol doi: 10.1016/j.jcmgh.2021.06.001 – volume: 10 start-page: 1433 year: 2015 ident: R69-20250603 article-title: Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis publication-title: Future Microbiol doi: 10.2217/fmb.15.66 – volume: 134 start-page: 783 year: 2021 ident: R5-20250603 article-title: Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020 publication-title: Chin Med J doi: 10.1097/CM9.0000000000001474 – volume: 68 start-page: 289 year: 2019 ident: R47-20250603 article-title: Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin publication-title: Gut doi: 10.1136/gutjnl-2018-317200 – volume: 115 start-page: E283 year: 2018 ident: R59-20250603 article-title: Colorectal cancer specific conditions promote Streptococcus gallolyticus gut colonization publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1715112115 – volume: 25 start-page: 32 year: 2017 ident: R63-20250603 article-title: Fecal clostridium symbiosum for noninvasive detection of early and advanced colorectal cancer: test and validation studies publication-title: EBioMedicine doi: 10.1016/j.ebiom.2017.10.005 – volume: 4 start-page: 181 year: 2013 ident: R75-20250603 article-title: Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer publication-title: Gut Microbes doi: 10.4161/gmic.23919 – volume: 70 start-page: 145 year: 2020 ident: R1-20250603 article-title: Colorectal cancer statistics, 2020 publication-title: CA Cancer J Clin doi: 10.3322/caac.21601 – volume: 23 start-page: 203 year: 2018 ident: R30-20250603 article-title: Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells publication-title: Cell Host Microbe doi: 10.1016/j.chom.2018.01.007 – volume: 11 start-page: 24 year: 2019 ident: R45-20250603 article-title: Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model publication-title: Gut Pathog doi: 10.1186/s13099-019-0306-9 – volume: 9 start-page: 474 year: 2018 ident: R84-20250603 article-title: The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get publication-title: Protein Cell doi: 10.1007/s13238-018-0543-6 – volume: 6 start-page: 161 year: 2015 ident: R43-20250603 article-title: Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain publication-title: Gut Microbes doi: 10.1080/19490976.2015.1039223 – volume: 53 start-page: 870 year: 2011 ident: R57-20250603 article-title: Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis publication-title: Clin Infect Dis doi: 10.1093/cid/cir609 – volume: 469 start-page: 456 year: 2020 ident: R68-20250603 article-title: Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating WNT signaling and gut microbiota publication-title: Cancer Lett doi: 10.1016/j.canlet.2019.11.019 – volume: 207 start-page: 211 year: 2018 ident: R62-20250603 article-title: Gut microbiome of Moroccan colorectal cancer patients publication-title: Med Microbiol Immunol doi: 10.1007/s00430-018-0542-5 – volume: 12 start-page: 372 year: 2020 ident: R15-20250603 article-title: Foes or friends? Bacteria enriched in the tumor microenvironment of colorectal cancer publication-title: Cancers (Basel) doi: 10.3390/cancers12020372 – volume: 13 start-page: 800 year: 2013 ident: R8-20250603 article-title: The microbiome and cancer publication-title: Nat Rev Cancer doi: 10.1038/nrc3610 – volume: 11 start-page: 506 year: 2014 ident: R65-20250603 article-title: Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2014.66 – volume: 19 start-page: e12714 year: 2017 ident: R46-20250603 article-title: Host cell binding of the flagellar tip protein of Campylobacter jejuni publication-title: Cell Microbiol doi: 10.1111/cmi.12714 – volume: 53 start-page: 631 issue: (Pt 3) year: 2003 ident: R56-20250603 article-title: Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov publication-title: Int J Syst Evol Microbiol doi: 10.1099/ijs.0.02361-0 – volume: 2020 start-page: 8884583 year: 2020 ident: R67-20250603 article-title: The protective role of probiotics against colorectal cancer publication-title: Oxid Med Cell Longev doi: 10.1155/2020/8884583 – volume: 16 start-page: 690 year: 2019 ident: R17-20250603 article-title: Gut microbiota in colorectal cancer: mechanisms of action and clinical applications publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-019-0209-8 – volume: 155 start-page: 383 year: 2018 ident: R19-20250603 article-title: Association between bacteremia from specific microbes and subsequent diagnosis of colorectal cancer publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.04.028 – volume: 13 start-page: 1 year: 2021 ident: R20-20250603 article-title: Gut microbiota: impacts on gastrointestinal cancer immunotherapy publication-title: Gut Microbes doi: 10.1080/19490976.2020.1869504 – volume: 234 start-page: 17023 year: 2019 ident: R80-20250603 article-title: Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy publication-title: J Cell Physiol doi: 10.1002/jcp.28436 – volume: 68 start-page: 394 year: 2018 ident: R2-20250603 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21492 – volume: 278 start-page: 119622 year: 2021 ident: R21-20250603 article-title: Restoration of dysbiotic human gut microbiome for homeostasis publication-title: Life Sci doi: 10.1016/j.lfs.2021.119622 – volume: 152 start-page: 851 year: 2017 ident: R36-20250603 article-title: Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-kappaB, and up-regulating expression of MicroRNA-21 publication-title: Gastroenterology doi: 10.1053/j.gastro.2016.11.018 – volume: 394 start-page: 1467 year: 2019 ident: R16-20250603 article-title: Colorectal cancer publication-title: Lancet doi: 10.1016/S0140-6736(19)32319-0 – volume: 359 start-page: 91 year: 2018 ident: R55-20250603 article-title: Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors publication-title: Science doi: 10.1126/science.aan3706 – volume: 11 start-page: 746 year: 2021 ident: R71-20250603 article-title: Probiotic-derived p8 protein induce apoptosis via regulation of RNF152 in colorectal cancer cells publication-title: Am J Cancer Res – volume: 9 start-page: 144 year: 2021 ident: R83-20250603 article-title: Dietary rice bran-modified human gut microbial consortia confers protection against colon carcinogenesis following fecal transfaunation publication-title: Biomedicines doi: 10.3390/biomedicines9020144 – volume: 16 start-page: 713 year: 2019 ident: R4-20250603 article-title: Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/s41575-019-0189-8 – volume: 15 start-page: 1674 year: 2013 ident: R64-20250603 article-title: CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen publication-title: Cell Microbiol – volume: 11 start-page: 588079 year: 2020 ident: R90-20250603 article-title: A holistic view of berberine inhibiting intestinal carcinogenesis in conventional mice based on microbiome-metabolomics analysis publication-title: Front Immunol doi: 10.3389/fimmu.2020.588079 – volume: 68 start-page: 1971 year: 2019 ident: R22-20250603 article-title: Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study publication-title: Gut doi: 10.1136/gutjnl-2019-318593 – volume: 6 start-page: 32013 year: 2015 ident: R89-20250603 article-title: Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment publication-title: Oncotarget doi: 10.18632/oncotarget.5166 – volume: 66 start-page: 683 year: 2017 ident: R3-20250603 article-title: Global patterns and trends in colorectal cancer incidence and mortality publication-title: Gut doi: 10.1136/gutjnl-2015-310912 – volume: 69 start-page: 93 year: 2019 ident: R9-20250603 article-title: Microbiome and colorectal cancer: roles in carcinogenesis and clinical potential publication-title: Mol Aspects Med doi: 10.1016/j.mam.2019.05.001 – start-page: djab125 year: 2021 ident: R23-20250603 article-title: Antibiotics use and subsequent risk of colorectal cancer: a Swedish nationwide population-based study publication-title: J Natl Cancer Inst – volume: 13 start-page: 2060 year: 2021 ident: R40-20250603 article-title: Colibactin-producing Escherichia coli induce the formation of invasive carcinomas in a chronic inflammation-associated mouse model publication-title: Cancers (Basel) doi: 10.3390/cancers13092060 – volume: 30 start-page: 11 year: 2011 ident: R58-20250603 article-title: The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role publication-title: J Exp Clin Cancer Res doi: 10.1186/1756-9966-30-11 – volume: 29 start-page: 959 year: 2021 ident: R70-20250603 article-title: Microbiota regulate innate immune signaling and protective immunity against cancer publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.03.016 – volume: 70 start-page: 2123 year: 2021 ident: R35-20250603 article-title: F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer publication-title: Gut doi: 10.1136/gutjnl-2020-322780 – volume: 23 start-page: 4422 year: 2017 ident: R42-20250603 article-title: Analysis of mucosa-associated microbiota in colorectal cancer publication-title: Med Sci Monit doi: 10.12659/MSM.904220 – volume: 75 start-page: 105 year: 2018 ident: R78-20250603 article-title: Postbiotics: an evolving term within the functional foods field publication-title: Trends Food Sci Technol doi: 10.1016/j.tifs.2018.03.009 – volume: 153 start-page: 1621 year: 2017 ident: R81-20250603 article-title: Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.08.022 – volume: 66 start-page: 462 year: 2013 ident: R24-20250603 article-title: Dysbiosis signature of fecal microbiota in colorectal cancer patients publication-title: Microb Ecol doi: 10.1007/s00248-013-0245-9 – volume: 161 start-page: 1552 year: 2021 ident: R31-20250603 article-title: Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosomes-packaged miR-149-3p publication-title: Gastroenterology doi: 10.1053/j.gastro.2021.08.003 – volume: 152 start-page: 1419 year: 2017 ident: R50-20250603 article-title: Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.01.009 – volume: 161 start-page: 1423 year: 2021 ident: R86-20250603 article-title: The sulfur microbial diet is associated with increased risk of early-onset colorectal cancer precursors publication-title: Gastroenterology doi: 10.1053/j.gastro.2021.07.008 – volume: 19 start-page: 56 year: 2021 ident: R88-20250603 article-title: Evodiamine inhibits high-fat diet-induced colitis-associated cancer in mice through regulating the gut microbiota publication-title: J Integr Med doi: 10.1016/j.joim.2020.11.001 – volume: 17 start-page: 107 year: 2019 ident: R82-20250603 article-title: Health-related quality of life of patients with inflammatory bowel disease in Singapore publication-title: Intest Res doi: 10.5217/ir.2018.00099 – volume: 69 start-page: 1988 year: 2020 ident: R53-20250603 article-title: A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8(+) T cells in mice publication-title: Gut doi: 10.1136/gutjnl-2019-320105 – volume: 9 start-page: 1111 year: 2021 ident: R54-20250603 article-title: A. Muciniphila suppresses colorectal tumorigenesis by inducing TLR2/NLRP3-mediated M1-like TAMs publication-title: Cancer Immunol Res doi: 10.1158/2326-6066.CIR-20-1019 – volume: 60 start-page: 208 year: 2015 ident: R27-20250603 article-title: The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients publication-title: Clin Infect Dis doi: 10.1093/cid/ciu787 – volume: 158 start-page: 322 year: 2020 ident: R6-20250603 article-title: Influence of the gut microbiome, diet, and environment on risk of colorectal cancer publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.06.048 – volume: 14 start-page: 195 year: 2013 ident: R34-20250603 article-title: Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin publication-title: Cell Host Microbe doi: 10.1016/j.chom.2013.07.012 |
| SSID | ssj0025576 ssib001521049 ssib051457378 ssib044732928 ssib008142972 ssib038074633 ssib017628699 ssib058574914 ssib020751800 ssib001103466 ssib022315857 ssib000827134 ssib006703066 ssib058492515 ssib051368197 |
| Score | 2.3623395 |
| SecondaryResourceType | review_article |
| Snippet | Colorectal cancer (CRC) is one of the most prevalent, most lethal cancers in the world. Increasing evidence suggests that the intestinal microbiota is closely... |
| SourceID | doaj pubmedcentral wanfang proquest pubmed crossref wolterskluwer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2922 |
| SubjectTerms | Antibiotics Bacteria Cancer therapies Cell growth Chemotherapy Colorectal cancer Colorectal Neoplasms - therapy Dysbiosis E coli Fecal Microbiota Transplantation Gastrointestinal Microbiome Homeostasis Humans Immunotherapy Inflammation Inflammatory bowel disease Metabolism Metabolites Microbiota MicroRNAs Pathogenesis Pathogens Prebiotics Probiotics Review Toxins Tumor Microenvironment Tumorigenesis Tumors |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYQUqteUB8U0m7bIHE1xI84ybFFoFWl7YmV9hb5FWhhs9UuaKX--s7ETroLSFyaY-w4zszYM5MZf0PIsWPaZkYpmjOtqOSyoaUpHS0ahz_dcidMlyD7Q42n8vssn22U-sKcsAAPHAh36sB9y4U2XDsmtQcNlmvFnc1BT_EmoJeCzuudqehq5XkRo5SKKrCB-kNzVXF6NqkCaGG8WJdOt6GUOuz-pwzOx3mTL9a6bXR7BS3rBUa3VzddcvuGirp4TfaibZl-Dd_0huz49i15OYnR83fkZILZd8ZTVF0unQ-ZLylYrinCV-P2ByNYFIXlPplenF-ejWmsl0AtrDtJrckqg4G5Ctw2D5tw1limMBTpMmAIk03lKqHLsuHCWQGeB2fGgMXoCg2szMR7stsuWn9I0sL4rlof99ZIZVipSwOWEvO6QKXHEyJ6gtU2goljTYvbug9qA5nrh2ROCB2e-h3ANJ7p_w15MfRFKOzuBghIHQWkfk5AEjLqOVnH9bmqETit4EKV8CVHQzOsLAyX6NYv7rFPhnUipawSchAYP8xEIKYOGHcJKbZEYmuq2y3tz-sOvRs8VCAgvPdLFJ5_s_pzbee_OILu484K1NoSqjqcjEUqcfwNRbEn4zxAA2Tyw_-g1kfyCocNCTsjsnu3vPefwOy6M5-7FfYXCuUf8w priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagCMQF8SZQIEhcTeN3ckJQUVVIy4lKe4v8SsujSdltVYlfz4zjZLuAYI-xk3Xm5RnP5BtCXgdmfeW0popZTSWXHa1dHajpAh66qSBcKpD9pA-P5MelWuYDt3Uuq5xsYjLUYfB4Rr6HUFeGC13zt2c_KHaNwuxqbqFxndxA6DIs6TLLTcCllMm5Sk01eELTp3ON2dtfNCN0Yf6xVFR3ZWtKCP5_czv_rJ68eWn7zvbHMHI5YI57_S2VuF_ZqA7ukjvZwyzfjSJxj1yL_X1ya5Fz6A_ImwXW4LlIcQML5elc_1KC_1oiiDUaQXiCR4FYPSRHBx8-7x_S3DWBetA-Sb2rGofpuQaCtwimuOo805iQDBWwhcmuCY2wdd1xEbyA-IMz58BvDMYCQyvxiOz0Qx-fkNK4mHr28eid1I7VtnbgL7FoDW59vCBiIljrM6Q4drb43k6pbSBz-zuZC0Lnu85GSI3_zH-PvJjnIiB2ujCsjtusX22AKF8J67gNTNoIjo6ymgevwJ3hXaUKsjtxss1aum43MlWQV_Mw6BcmTWwfhwucU2G3SCmbgjweGT-vRCCyDrh4BTFbIrG11O2R_stJwvCGOBUICP_7MgvPZlU_T_zpV47Q-2hfgVpbQtWO38cilTgeRlGcyTgfAQIq-fTfL_qM3MYbxoKcXbJzvrqIz8GtOncvku78AgDkF-A priority: 102 providerName: ProQuest |
| Title | Microbe-based management for colorectal cancer |
| URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00029330-202112200-00004 https://www.ncbi.nlm.nih.gov/pubmed/34855639 https://www.proquest.com/docview/2612723682 https://www.proquest.com/docview/2606930449 https://d.wanfangdata.com.cn/periodical/zhcmj202124004 https://pubmed.ncbi.nlm.nih.gov/PMC8710322 https://doaj.org/article/d69053ab2ad14ae0815a62dc52932f05 |
| Volume | 134 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB71IRAXxLOEliVIXF3FjmMnB4TaqqVC2gohVtpb5FdaaJuFbasCv56ZvCBQBHvYw9rJOvPwzHgm3wC89Ny4xCrFMm4Uk0JWLLe5Z7rydOiW-dQ2BbJH6nAm386z-Qr0PVs7Al7cGNpRP6nZ8mz765dvr1HhX_UAjHvTooUh7D4cFWcV1tE2aVLVqRzyCug_t-3mMokhmJK8f5nuL3cZGasG0_8mR_TPespb16auTH2MI9cLynpfnDZF77-YroN7cLfzOeOdVkjuw0qoH8DtaZdVfwjbU6rKs4GRSfPx-VARE6NHGxOsNW2LeAdHIrJ8BLOD_Q97h6zro8Ac6qNkziaFpYRdgeFcwM05qRxXlKL0CTKKy6rwRWryvBKpdylGJIJbi56k1wZZnKSPYa1e1OEJxNqGpoufCM5KZXlucoseFA9GkzEUEaQ9wUrXgYxTr4uzsk92I5nL38kcARuu-tyCbPxj_i7xYphLENnND4vlcdlpXOkx7s9SY4XxXJqArk9mlPAuQwdHVEkWwVbPybIXu5IA1bRIVY5P8mIYRo2jNIqpw-KK5iTUP1LKIoKNlvHDSlLC2kGnLwI9EonRUscj9ceTBtUbI1ckIP7v8054fq7q-4k7_yQIjJ92XKTWSKjK9o1ZopKg4ylGM7kQLWRAIp_-x5Nswh26qq3T2YK1y-VVeIbe1qWdwKqe6wms7-4fvXs_ac4s8PvNnE8a1foBCsohuA |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrXhcEG8ChQYJjqaJ4zjJASFaWm1pd4VQK_UW_ErLo9my22oFP4rfyEzipF1AcOoeYzvrjMfjz57xNwDPbaxMpKVkaawkE1xULNe5ZVll6dAttYluAmTHcrgv3h2kB0vws7sLQ2GVnU1sDLWdGDojXyOqq4wnMuevT74xyhpF3tUuhUarFjvu-xy3bLNX229xfF9wvrW5tzFkPqsAM6idghkdFZrcVwVubhyaqqgysSSHnY2w27GoClskKs8rnliTID7nsdaIq2ym8IOjBN97BZZFgm0GsLy-OX7_od_ipWnmvaOSScRe3WW9IlvbGBUtWaL_xU0Y34XFsMkZ8Deg-2e85tW5qitVH2LJfEJe9dmXJqj-wtK4dQtuekwbvmmV8DYsufoOXBt5r_1deDmiqD_tGC2ZNjzuI25CRMwh0WaT2cU3GFLB6T3YvxSJ3odBPandQwgz7ZosgdwZLaSOc5VrRGixUxkttjyApBNYaTyJOeXS-Fp2znQUc_m7mANgfauTlsTjP_XXaSz6ukTB3TyYTA9LP6NLKws0YEpzZWOhHEKrVEluTYoAildRGsBKN5Kltwuz8lyLA3jWF-OMJjeNqt3kjOpElJ9SiCKAB-3A9z1JiMsHQWUA2YJKLHR1saT-dNSwhuPOGAWI_7vqlee8Vz-OzPFnTmT_ZNFRWgtKVbY3cklKnI6_GNWMOW8pCSLx6N8fugrXh3uj3XJ3e7zzGG5Q4zYcaAUGp9Mz9wRB3al-6mdSCB8ve_L-ApwxVTM |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdGJyZeEN8UBgsSypunxHGc5CEPo00Zg3aTusF4iuw42QcsmdqOCf567hInED6E6Euq2knc8935znf-HSEvtSszRwlBfVcKyhkvaKhCTYNC46abrz1VJ8jOxO4R3zv2j9dImzqEh8-Wl9t4qdU0fsFyOOgXHsZ7c3s0H8Uf7VnyYR7P7IOd10m9TY1JEvbBeBJ_tcdx9aVY2eP9uMVnHE2jBqXQfFyQqxtkPQyFwwdkff99kow7H833AxPeFFSA8dSetvvLc3qrWQ36_ydL9feEy5vXsixkeQIt1xWGxZef6qz4n9a2yR1y2xil1k7DRXfJWl7eIxtTE3a_T7anmLancoprnrYuupQZC0xeC3GvUW_CEzLkocUDcjRJDke71BRaoBkILKeZciKFEb0I_L0ctLdTZK7AGKZ2YCZdXkQ68mQYFszTmQcuC3OVAlNTBxJ4wPEekkFZlfljYgUqr8v8sTxTXCg3lKECE8vNZYCrJRsSryVYmhkUciyG8Tlto-FA5vRXMg8J7e66bFA4_tH_Fc5F1xcxtOsfqsVJakQy1SICDSQVk9rlMgfbyJeC6cwHC4gVjj8km-1MpkawlykirgXMEyH8kxddM4gkxllkmVdX2MfBApOcR0PyqJn4biQegvGAVTgkQY8lekPtt5RnpzXsN7i2QEB475Zhnh-j-naaXZwzROtHlQzU6jFV2hypRSox3L-i2NNlrMEUcPiT_-y_RTZA1tJ3b2Zvn5Jb2Njk92ySwWpxlT8DK22lnhvJ-g54Yyrw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Microbe-based+management+for+colorectal+cancer&rft.jtitle=Chinese+medical+journal&rft.au=Gao%2C+Zi-Yun&rft.au=Cui%2C+Zhe&rft.au=Yan%2C+Yu-Qing&rft.au=Ning%2C+Li-Jun&rft.date=2021-12-01&rft.issn=2542-5641&rft.eissn=2542-5641&rft.volume=134&rft.issue=24&rft.spage=2922&rft_id=info:doi/10.1097%2FCM9.0000000000001887&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhcmj%2Fzhcmj.jpg |